MENU
CYTO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Altamira Therapeutics (CYTO) Ownership - Who owns Altamira Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2 Church Street
Phone
+1 441 295-5950
Employees
18
Web
https://www.altamiratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62M
P/E Ratio
0.24
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CYTO
Capitalization
1.63M
P/E Ratio
0.24
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
0.26
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
1.38
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
5.42K
Shares Outstanding - Current
3.78M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-87.644
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Church Street
Phone
+1 441 295-5950
Employees
18
Web
https://www.altamiratherapeutics.com